Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer

医学 列线图 乳腺癌 肿瘤科 内科学 流行病学 妇科 癌症
作者
Jingjing Zhu,Hongming Zheng,Chenyang Ge,Hanyang Lin,Kai‐Jie Yu,Lidong Wu,Dan Li,Su Zhou,Wei‐Hua Tang,Qinghua Wang,Zhengyuan Xia,Xianyu Jin,Xianglai Xu,Jinlin Du,Jianfei Fu
出处
期刊:Clinical Breast Cancer [Elsevier BV]
卷期号:22 (3): e296-e309 被引量:2
标识
DOI:10.1016/j.clbc.2021.08.008
摘要

More than half of early breast cancer recurrences occur after 5 years from the initial diagnosis. An individualized estimate of the risk of late-period breast cancer-specific death (LP-BCSD) after 5 years of endocrine therapy (ET) can improve decision-making for extended endocrine therapy (EET).A total of 147,059 eligible patients with breast cancer who survived 5+ years after diagnosis between 1990 and 2007 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate analyses based on the competing risk regression model were used to evaluate predictive factors for high risk of LP-BCSD or late-period non-breast cancer-specific death (LP-non-BCSD). Significant factors were used to build a nomogram to individualize estimates of LP-BCSD or LP-non-BCSD.The 5- and 10-year LP-BCSD rates were 5.7% and 10.1%, respectively, and the 5- and 10-year LP-non-BCSD rates were 6.7% and 15.5%, respectively. Young age, black race, single marital status, poor differentiation, large tumor size, lymph node metastasis, and estrogen receptor-positive/progesterone receptor-negative (ER+/PR-) status were independent predictive factors for high risk of LP-BCSD. Age was the most important factor for predicting high risk of LP-non-BCSD. The nomograms, which were based on significant factors identified by the competing risk regression model. A risk score system based on the competing risk nomogram was established to describe the relative risk of LP-BCSD and LP-non-BCSD.This study explored the novel endpoint of LP-BCSD for further clinical trials. The risk score system might be highly useful for patient counseling, especially in discussing EET options with elderly or comorbid patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lemon完成签到,获得积分10
刚刚
传奇3应助duckspy采纳,获得30
1秒前
陈木木完成签到,获得积分10
2秒前
可可西里完成签到,获得积分10
3秒前
奋斗蜗牛完成签到,获得积分10
3秒前
CipherSage应助眼睛大的擎苍采纳,获得10
3秒前
打打应助小小酥采纳,获得10
4秒前
fox完成签到 ,获得积分10
4秒前
僦是卜够完成签到 ,获得积分10
5秒前
小马甲应助嘉梦采纳,获得10
8秒前
qiqi完成签到,获得积分10
9秒前
9秒前
科研乞丐应助Jerry采纳,获得20
10秒前
vsvsgo发布了新的文献求助10
12秒前
Jeffrey完成签到,获得积分10
13秒前
明理采珊完成签到,获得积分10
13秒前
lll发布了新的文献求助10
13秒前
vsvsgo发布了新的文献求助10
16秒前
慎之完成签到 ,获得积分10
16秒前
我是微风完成签到,获得积分10
16秒前
传奇3应助木子采纳,获得30
18秒前
vsvsgo发布了新的文献求助10
20秒前
feitian201861完成签到,获得积分10
20秒前
22秒前
mmr完成签到 ,获得积分10
23秒前
大知闲闲完成签到,获得积分10
24秒前
陌陌完成签到,获得积分10
24秒前
vsvsgo发布了新的文献求助10
24秒前
科研通AI2S应助sunyanghu369采纳,获得30
26秒前
wlp鹏完成签到,获得积分10
28秒前
vsvsgo发布了新的文献求助10
28秒前
zcious完成签到,获得积分10
29秒前
Joker完成签到,获得积分10
30秒前
迷你的雁枫完成签到 ,获得积分10
31秒前
时尚俊驰发布了新的文献求助20
31秒前
luluyang完成签到 ,获得积分10
31秒前
Theprisoners举报活性炭求助涉嫌违规
32秒前
Weiyu完成签到 ,获得积分10
32秒前
vsvsgo发布了新的文献求助30
32秒前
舆上帝同行完成签到,获得积分10
33秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022